LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 322 of 520
Next
>>
>
8026 to 8050 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	AZD 5438	1.11	uM	LJP6	3	J03	72	hr	1334	1562	3921	0.3983	0.1064
BT-20	AZD 5438	3.33	uM	LJP6	1	J02	72	hr	1334	1139	3955	0.2879	-0.0962
BT-20	AZD 5438	3.33	uM	LJP6	2	J02	72	hr	1334	984	3899	0.2524	-0.1789
BT-20	AZD 5438	3.33	uM	LJP6	3	J02	72	hr	1334	934	3921	0.2382	-0.2051
BT-20	AZD 5438	10	uM	LJP6	1	J01	72	hr	1334	473	3955	0.1196	-0.4841
BT-20	AZD 5438	10	uM	LJP6	2	J01	72	hr	1334	403	3899	0.1034	-0.5390
BT-20	AZD 5438	10	uM	LJP6	3	J01	72	hr	1334	347	3921	0.0885	-0.5795
BT-20	Pelitinib	0.04	uM	LJP5	1	I18	72	hr	1334	3821	3930	0.9721	0.9640
BT-20	Pelitinib	0.04	uM	LJP5	2	I18	72	hr	1334	4101	4051	1.0123	1.0154
BT-20	Pelitinib	0.04	uM	LJP5	3	I18	72	hr	1334	4066	4117	0.9875	0.9845
BT-20	Pelitinib	0.12	uM	LJP5	1	I17	72	hr	1334	3656	3930	0.9301	0.9091
BT-20	Pelitinib	0.12	uM	LJP5	2	I17	72	hr	1334	3832	4051	0.9459	0.9318
BT-20	Pelitinib	0.12	uM	LJP5	3	I17	72	hr	1334	3920	4117	0.9520	0.9404
BT-20	Pelitinib	0.37	uM	LJP5	1	I16	72	hr	1334	3305	3930	0.8408	0.7894
BT-20	Pelitinib	0.37	uM	LJP5	2	I16	72	hr	1334	3228	4051	0.7968	0.7356
BT-20	Pelitinib	0.37	uM	LJP5	3	I16	72	hr	1334	3359	4117	0.8158	0.7645
BT-20	Pelitinib	1.11	uM	LJP5	1	I15	72	hr	1334	2833	3930	0.7207	0.6209
BT-20	Pelitinib	1.11	uM	LJP5	2	I15	72	hr	1334	3159	4051	0.7798	0.7124
BT-20	Pelitinib	1.11	uM	LJP5	3	I15	72	hr	1334	3249	4117	0.7890	0.7287
BT-20	Pelitinib	3.33	uM	LJP5	1	I14	72	hr	1334	2539	3930	0.6459	0.5109
BT-20	Pelitinib	3.33	uM	LJP5	2	I14	72	hr	1334	2758	4051	0.6808	0.5732
BT-20	Pelitinib	3.33	uM	LJP5	3	I14	72	hr	1334	2836	4117	0.6887	0.5900
BT-20	Pelitinib	10	uM	LJP5	1	I13	72	hr	1334	608	3930	0.1547	-0.3962
BT-20	Pelitinib	10	uM	LJP5	2	I13	72	hr	1334	547	4051	0.1350	-0.4270
BT-20	Pelitinib	10	uM	LJP5	3	I13	72	hr	1334	619	4117	0.1503	-0.3767

|<
<<
Previous
Page 322 of 520
Next
>>
>
8026 to 8050 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)